Findings seen among patients receiving letter during reopening following cancellation of in-person care during COVID-19<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, July 7, 2021 (HealthDay News) — Patient engagement strategies appear to yield few return visits upon reopening during COVID-19 for patients who cancelled in-person care during the earlier portion of the pandemic, according to a research letter published online June 30 in JAMA Network Open<\/em>.<\/p>\n Anne R. Cappola, M.D., from the University of Pennsylvania in Philadelphia, and colleagues conducted a randomized clinical trial to determine whether targeted messaging could improve the return to in-person visits for 11,120 adult patients who had canceled in-person appointments, procedures, or surgical procedures (March 9 through June 7, 2020) and had not rescheduled. Patients were randomly assigned to no letter versus letter (1:9), tailored versus standard letter (1:1), or electronic versus mail letter (1:1).<\/p>\n The researchers found that in-person return visits within one month were low and did not significantly differ between patients who did or did not receive a letter (5.0 versus 4.1 percent). However, patients receiving any letter had a significantly higher percentage of telemedicine visits and future scheduled visits within one month (telemedicine visits: 1.3 versus 0.4 percent; future visits: 14.4 versus 11.7 percent). Compared with standard letters, patients receiving the tailored letter scheduled more visits (15.3 versus 13.4 percent). Patients with a household income below the median were significantly more likely to schedule a visit when mailed a letter versus when they received an electronic letter.<\/p>\n “Strategies to improve patient engagement, with attention to message framing and delivery mode, are needed to encourage continuity of health care in the era of COVID-19,” the authors write.<\/p>\n